Table 5 of
Brzović-Šarić, Mol Vis 2015; 21:649-664.
Table 5. Correlation analysis of measured parameters in vitreous and serum of proliferative diabetic retinopathy (PDR) patients.
Vitreous | Serum | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Parameter | VEGF (pg/l) | AOPP (µM) | LPO (µM) | MDA (nmol/ml) | SOD (U/ml) | GSH (µmol/ml) | VEGF (pg/l) | AOPP (µM) | LPO (µM) | MDA (nmol/ml) | SOD (U/ml) | GSH (µmol/ml) |
Vitreous | ||||||||||||
VEGF (pg/l) | / | 0.129 | -0.081 | 0.309 | -0.477# | 0.198 | 0.357# | 0.230 | 0.045 | -0.008 | 0.632# | -0.102 |
AOPP (µM) | 0.298 | / | 0.159 | -0.048 | 0.021 | 0.079 | -0.049 | -0.076 | 0.147 | -0.042 | 0.123 | -0.061 |
LPO (µM) | 0.471 | 0.198 | / | 0.457# | -0.441# | 0.387# | 0.367# | 0.299# | 0.838# | 0.095 | 0.742# | -0.277 |
MDA (nmol/ml) | 0.031 | 0.744 | 0.001 | / | -0.251 | -0.021 | 0.135 | 0.201 | 0.346# | -0.184 | 0.406# | 0.036 |
SOD (U/ml) | <0.001 | 0.872 | <0.001 | 0.086 | / | -0.238 | -0.141 | -0.144 | -0.421# | 0.075 | -0.312# | -0.049 |
GSH (µmol/ml) | 0.072 | 0.533 | <0.001 | 0.886 | 0.035 | / | 0.239 | 0.185 | 0.371# | 0.016 | 0.361# | -0.259 |
Serum | ||||||||||||
VEGF (pg/l) | 0.001 | 0.697 | 0.001 | 0.355 | 0.223 | 0.029 | / | 0.152 | 0.402# | -0.049 | 0.354# | -0.031 |
AOPP (µM) | 0.059 | 0.544 | 0.013 | 0.169 | 0.264 | 0.137 | 0.216 | / | 0.375# | 0.012 | 0.350# | 0.116 |
LPO (µM) | 0.356 | 0.235 | <0.001 | 0.015 | <0.001 | <0.001 | <0.001 | 0.002 | / | 0.141 | 0.778# | -0.214 |
MDA (nmol/ml) | 0.941 | 0.743 | 0.395 | 0.215 | 0.521 | 0.887 | 0.665 | 0.924 | 0.208 | / | 0.119 | -0.220# |
SOD (U/ml) | <0.001 | 0.371 | <0.001 | 0.006 | 0.011 | 0.002 | 0.002 | 0.008 | <0.001 | 0.318 | / | -0.418# |
GSH (µmol/ml) | 0.391 | 0.663 | 0.016 | 0.811 | 0.692 | 0.028 | 0.798 | 0.391 | 0.066 | 0.050 | <0.001 | / |